dc.contributor.author |
Weidmann, M.
|
|
dc.contributor.author |
Avsic-Zupanc, T.
|
|
dc.contributor.author |
Bino, S.
|
|
dc.contributor.author |
Bouloy, M.
|
|
dc.contributor.author |
Burt, F.
|
|
dc.contributor.author |
Chinikar, S.
|
|
dc.contributor.author |
Christova, I.
|
|
dc.contributor.author |
Dedushaj, I.
|
|
dc.contributor.author |
El-Sanousi, A. A.
|
|
dc.contributor.author |
Eladi, N.
|
|
dc.contributor.author |
Weber, F.
|
|
dc.contributor.author |
Hewson, R.
|
|
dc.contributor.author |
Hufert, F.
|
|
dc.contributor.author |
Humolli, I.
|
|
dc.contributor.author |
Koçak Tufan, Z.
|
|
dc.contributor.author |
Korukluoglu, G.
|
|
dc.contributor.author |
Leyssen, P.
|
|
dc.contributor.author |
Mirazimi, A.
|
|
dc.contributor.author |
Neyts, J.
|
|
dc.contributor.author |
Niedrig, M.
|
|
dc.contributor.author |
Ozkul, A.
|
|
dc.contributor.author |
Papa, A.
|
|
dc.contributor.author |
Paweska, Janusz Tadeusz
|
|
dc.contributor.author |
Sall, A. A.
|
|
dc.contributor.author |
Schmaljohn, C.
|
|
dc.contributor.author |
Swanepoel, Robert
|
|
dc.contributor.author |
Jansen van Vuren, P.
|
|
dc.contributor.author |
Uyar, Y.
|
|
dc.contributor.author |
Zeller, H.
|
|
dc.date.accessioned |
2017-01-18T08:20:43Z |
|
dc.date.available |
2017-01-18T08:20:43Z |
|
dc.date.issued |
2016-11 |
|
dc.description.abstract |
In countries from which Crimean-Congo haemorrhagic fever (CCHF) is absent, the causative virus
CCHF virus (CCHFV) is classified as a hazard group 4 agent and handled in containment level 4. In
contrast, most endemic countries out of necessity have had to perform diagnostic tests under
biosafety level (BSL) 2 or 3 conditions. In particular, Turkey and several of the Balkan countries
have safely processed more than 100000 samples over many years in BSL-2 laboratories. It is
therefore advocated that biosafety requirements for CCHF diagnostic procedures should be
revised, to allow the required tests to be performed under enhanced BSL-2 conditions with
appropriate biosafety laboratory equipment and personal protective equipment used according to
standardized protocols in the affected countries. Downgrading of CCHFV research work from Cl-
4,BSL-4 to Cl-3 ,BSL-3 should also be considered. |
en_ZA |
dc.description.department |
Veterinary Tropical Diseases |
en_ZA |
dc.description.librarian |
hb2017 |
en_ZA |
dc.description.sponsorship |
Funding was received through CCH Fever Network (Collaborative Project) supported by the
European Commission under the Health Cooperation Work Program of the 7th Framework
Program (Grant agreement no. 260427) (http://www.cch-fever.eu/). |
en_ZA |
dc.description.uri |
http://vir.sgmjournals.org |
en_ZA |
dc.identifier.citation |
Weidmann, M, Avsic-Zupanc, T, Bino, S, Bouloy, M et al 2016, 'Biosafety standards for working with Crimean-Congo hemorrhagic fever virus', Journal of General Virology, vol. 97, no. 11, pp. 2799-2808. |
en_ZA |
dc.identifier.issn |
0022-1317 (print) |
|
dc.identifier.issn |
1465-2099 (online) |
|
dc.identifier.other |
10.1099/jgv.0.000610 |
|
dc.identifier.uri |
http://hdl.handle.net/2263/58547 |
|
dc.language.iso |
en |
en_ZA |
dc.publisher |
Society for General Microbiology |
en_ZA |
dc.rights |
© 2016 Society for General Microbiology. This is an author manuscript that has been accepted for publication in Microbiology, copyright Society for General Microbiology, but has not been copy-edited, formatted or proofed. Cite this article as appearing in Journal of General Virology, vol. 97, no. 11, pp. 2799-2808, 2016. doi : 10.1099/jgv.0.000610. |
en_ZA |
dc.subject |
Nairovirus genus |
en_ZA |
dc.subject |
Bunyaviridae |
en_ZA |
dc.subject |
Causes a tick-borne zoonotic infection |
en_ZA |
dc.subject |
Crimean-Congo haemorrhagic fever virus (CCHFV) |
en_ZA |
dc.subject |
Crimean-Congo haemorrhagic fever (CCHF) |
en_ZA |
dc.subject |
Biosafety level (BSL) |
en_ZA |
dc.title |
Biosafety standards for working with Crimean-Congo hemorrhagic fever virus |
en_ZA |
dc.type |
Postprint Article |
en_ZA |